Patent applications and USPTO patent grants for SmartCells,Inc..The latest application filed is for "conjugate based systems for controlled insulin delivery".
Patent | Date |
---|---|
Conjugate based systems for controlled insulin delivery Grant 11,413,352 - Moyes , et al. August 16, 2 | 2022-08-16 |
Conjugate Based Systems For Controlled Insulin Delivery App 20210177981 - Yan; Lin ;   et al. | 2021-06-17 |
Conjugate based systems for controlled drug delivery Grant 10,398,781 - Zion , et al. Sep | 2019-09-03 |
Conjugate Based Systems For Controlled Drug Delivery App 20180064824 - Zion; Todd C. ;   et al. | 2018-03-08 |
Binding-site modified lectins and uses thereof Grant 9,745,355 - Zion , et al. August 29, 2 | 2017-08-29 |
Conjugate based systems for controlled drug delivery Grant 9,579,391 - Zion , et al. February 28, 2 | 2017-02-28 |
Crystalline Insulin-conjugates App 20170022262 - Lancaster; Thomas M. ;   et al. | 2017-01-26 |
Crystalline insulin-conjugates Grant 9,463,249 - Lancaster , et al. October 11, 2 | 2016-10-11 |
Conjugate Based Systems For Controlled Drug Delivery App 20160193351 - Zion; Todd C. ;   et al. | 2016-07-07 |
Conjugate based systems for controlled drug delivery Grant 9,265,838 - Zion , et al. February 23, 2 | 2016-02-23 |
Conjugate Based Systems For Controlled Drug Delivery App 20150265717 - Zion; Todd C. ;   et al. | 2015-09-24 |
Exogenously triggered controlled release materials and uses thereof Grant 9,114,176 - Zion , et al. August 25, 2 | 2015-08-25 |
Terminally-functionalized conjugates and uses thereof Grant 9,095,623 - Zion , et al. August 4, 2 | 2015-08-04 |
Recombinantly expressed insulin polypeptides and uses thereof Grant 9,074,015 - Lancaster , et al. July 7, 2 | 2015-07-07 |
Conjugate based systems for controlled drug delivery Grant 9,050,370 - Zion , et al. June 9, 2 | 2015-06-09 |
Drug-ligand conjugates, synthesis thereof, and intermediates thereto Grant 8,933,207 - Chen , et al. January 13, 2 | 2015-01-13 |
Crystalline insulin-conjugates Grant 8,906,850 - Zion , et al. December 9, 2 | 2014-12-09 |
Binding-site Modified Lectins And Uses Thereof App 20140342980 - Zion; Todd C. ;   et al. | 2014-11-20 |
Exogenously triggered controlled release materials and uses thereof Grant 8,846,103 - Zion , et al. September 30, 2 | 2014-09-30 |
Conjugate Based Systems For Controlled Drug Delivery App 20140274888 - Zion; Todd C. ;   et al. | 2014-09-18 |
Crystalline Insulin-conjugates App 20140275476 - Lancaster; Thomas M. ;   et al. | 2014-09-18 |
Exogenously Triggered Controlled Release Materials And Uses Thereof App 20140256622 - Zion; Todd C. ;   et al. | 2014-09-11 |
Methods for reducing the mitogenicity of lectin compositions Grant 8,729,242 - Lancaster , et al. May 20, 2 | 2014-05-20 |
Terminally Functionalized Conjugates And Uses Thereof App 20140121159 - Zion; Todd C. ;   et al. | 2014-05-01 |
Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator Grant 8,697,643 - Lancaster , et al. April 15, 2 | 2014-04-15 |
Soluble Non-depot Insulin Conjugates And Uses Thereof App 20140037699 - Zion; Todd C. ;   et al. | 2014-02-06 |
Polynucleotide aptamer-based cross-linked materials and uses thereof Grant 8,603,529 - Zion , et al. December 10, 2 | 2013-12-10 |
Soluble non-depot insulin conjugates and uses thereof Grant 8,569,231 - Zion , et al. October 29, 2 | 2013-10-29 |
Drug-ligand Conjugates, Synthesis Thereof, And Intermediates Thereto App 20130190475 - Chen; Zhiyu ;   et al. | 2013-07-25 |
Polymer-drug Conjugates App 20120135919 - Lancaster; Thomas M. ;   et al. | 2012-05-31 |
Methods For Reducing The Mitogenicity Of Lectin Compositions App 20100130726 - LANCASTER; Thomas M. ;   et al. | 2010-05-27 |
Methods for reducing the mitogenicity of lectin compositions Grant 7,687,608 - Lancaster , et al. March 30, 2 | 2010-03-30 |
Polymer-drug conjugates App 20070099820 - Lancaster; Thomas M. ;   et al. | 2007-05-03 |
SEC | 0001304807 | SmartCells, Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.